Journals / Osteoporoz Dünyasından / 2003 / Cilt: 9 - Sayı: 2

Beta2-microglobulin levels in patients with postmenopausal osteoporosis

Postmenopozal osteoporozlu hastalarda Beta2-mikroglobulin düzeyleri

Pages
49–53
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although high levels of ß2 microglobulin in postme-nopausal osteoporotic women suggest that it might reflect osteoclastic activity, the possible role of this polypeptide in the pathogenesis of increased bone resorption, needs further investigation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to evaluate the concentrations of ß2 microglobulin in patients with postmenopausal osteoporosis and compare the results with the ones obtained from healthy postmenopausal women.
📊
Key Findings & Data:We also evaluated the relationships between ß2 microglobulin and bone mineral density (BMD), parathyroid hormone (PTH), calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), and 24 hr urinary calcium levels.
💡
Conclusion & Impact:Although high levels of ß2 microglobulin in postme-nopausal osteoporotic women suggest that it might reflect osteoclastic activity, the possible role of this polypeptide in the pathogenesis of increased bone resorption, needs further investigation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Alkalin fosfataz · Osteoporoz · postmenopozal

Abstract

The aim of this study was to evaluate the concentrations of ß2 microglobulin in patients with postmenopausal osteoporosis and compare the results with the ones obtained from healthy postmenopausal women. We also evaluated the relationships between ß2 microglobulin and bone mineral density (BMD), parathyroid hormone (PTH), calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), and 24 hr urinary calcium levels. For this aim, 31 postmenopausal women with osteoporosis and 22 healthy postmenopausal women were included in the study. DXA was used for the measurement of BMD of the lumbar spine and proximal femur. Laboratory assessments included serum Ca, P, ALP, PTH, ß2 microglobulin levels and 24 hour urinary calcium. BMD at the lumbar spine (p< 0.001 ), femur neck (p<0.001), ward triangle (p<0.001), and trochanteric region (p<0.05) was significantly lower and serum ß2 microglobulin (p<0.05), alkaline phosphotase (p<0.05), and parathyroid hormone (p<0.05) levels were found to be significantly higher in postmenopausal osteoporotic women as compared to healthy controls. However, ß2 microglobulin was not associated with BMD at any of the measured regions and no association was found between serum PTH, ALP, Ca, P, and 24 hour urinary calcium values. Although high levels of ß2 microglobulin in postme-nopausal osteoporotic women suggest that it might reflect osteoclastic activity, the possible role of this polypeptide in the pathogenesis of increased bone resorption, needs further investigation.

Özet

Bu çalışmanın amacı, postmenopozal osteoporozu olan hastalarda serum ß2 mikroglobulin düzeylerini araştırmak ve elde edilen sonuçları sağlıklı postmenopozal kadınlarla karşılaştırmaktı. Ayrıca, ß2 mikroglobulin düzeyleri ile kemik mineral yoğunluğu (KMY), parathormon (PTH), alkalen fosfotaz (ALP), kalsiyum (Ca), fosfor (P) ve 24 saatlik idrardaki kalsiyum düzeyleri arasındaki ilişki değerlendirildi. Bu amaçla osteoporozu olan 31 postmenopozal hasta ve kontrol grubu olarak yine postmenopozal dönemde 22 sağlıklı kadın çalışmaya dahil edildi, tomber omurga ve proksimal fernurdan gerçekleştirilen KMY ölçümleri için DXA yöntemi kullanıldı. Laboratuar analizlerinde serum ß2 mikroglobulin, PTH, ALP, Ca, P ve 24 saatlik idrardaki Ca düzeyleri belirlendi. Kontrollerle karşılaştırıldığında, osteoporozlu hastaların lomber bölge (p<0.001), femur boynu (p<0.001), ward üçgeni (p<0.001) ve trokanterik bölge (p<0.05) KMY' lan düşük, serum ß2 mikroglobulin, ALP ve PTH düzeyleri yüksek olarak bulundu (p<0.05). Bununla birlikte, ß2 mikroglobulin ile ölçüm yapılan bölgelerdeki KMY ve serum PTH, ALP, Ca, P ve 24 saatlik idrar Ca düzeyleri arasında bir ilişki saptanmadı. Postmenopozal osteoporotik kadınlarda saptadığımız yüksek ß2 mikroglobulin düzeyleri, bu polipeptidin osteoklastik aktiviteyi yansıtabileceğini düşündürmekle birlikte, artmış kemik rezorpsiyonunun patogenezindeki olası rolü konusunda daha ileri araştırmalar yapılması kanısındayız.

🔖

Cite This Article

TAŞÇIOĞLU, F., TABAK, Y., ULAŞAN, P., ÖNER, C. (2003). Beta2-microglobulin levels in patients with postmenopausal osteoporosis. Osteoporoz Dünyasından, Cilt: 9 - Sayı: 2, 49–53. https://ajindex.com/articles/286822

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Cummings SR, Kelsey JL, Nevitt MC, O’Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7: 178-207
  2. Ravn P, Fledelius C, Rosenquist C, Overgaard K, Christiansen C. High bone turnover is associated with low bone mass in both pre- and postmenopausal women. Bone 1996; 19: 291-8
  3. Melton LJ, Sundeep K, Atkinson EJ, O’Fallon WM, et al. Relationship of bone turnover to bone density and fractures. J Bone Miner Res 1997; 12: 1083-91
  4. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas BD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994; 79: 1693-700
  5. Rico H, Ripoll E, Revilla M, et al. _2-Microglobulin in postmenopausal osteoporosis. Calcif Tissue Int 1993; 53: 78-80
  6. Ripoll E, Arribas I, Relea M, et al. Beta-2-microglobulin in diseases with high bone remodelling. Calcif Tissue Int 1995; 57: 272-6
  7. Canalis E, McCarthym T, Centrelle M. Growth factors from adult bovine bone. Calcif Tissue Int 1988; 43: 346-51
  8. Sprague SM, Popovtzer MM. Is _2-microglobulin a mediator of bone disease? Kidney Int 1995; 47: 1-6
  9. Klein T, Levin I, Niska A, et al. Correlation between tumour and serum beta 2 m expression in patients with breast cancer. Eur J Immunogenet 1996; 23: 417-423
  10. Walters MT, Stevenson FK, Goswami R, et al. Comparison of serum and synovial fluid concentrations of _2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis. Ann Rheum Dis 1989; 48: 905-11
  11. Moe SM, Sprague SM. Beta2-microglobulin induces calcium efflux from cultured neonatal mouse calvariae. Am J Physiol 1992; 263: 240-245
  12. Fiore CE, Foti R, Tamburino C. Metabolic-dependent increase of serum _2-microglobulin levels in patients with Paget’s disease of bone. Horm Metab Res 1992; 24: 143-144
  13. Eriksen EF, Hodgson SF, Eastell R, et al. Cancellous bone remodelling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res 1990; 5: 311-319
  14. Kanis JA, Glüer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 2000; 11: 192-202
  15. Rico H, Ripoll E, Arribas I, et al. _2-microglobulin in Paget’s bone disease. Calcif Tissue Int 1994; 54: 389-91
  16. Cantatore FP, Loperdifo MC, Mancini L, et al. Effect of calc